Wyeth Prevnar Capacity Expansion Planned For 2003; Shortage Until Then
Executive Summary
Wyeth plans to add a second Prevnar production line during 2003 to help alleviate supply problems with the pneumococcal conjugate vaccine
You may also be interested in...
Premarin/Prempro Rxs Stabilize; Wyeth Predicts $300 Mil. Drop In 2nd Half
Wyeth is seeing some stabilization in the Premarin franchise despite a 40% drop in prescriptions for Prempro and a 15% decline in Premarin scripts since release of the Women's Health Initiative study results
Premarin/Prempro Rxs Stabilize; Wyeth Predicts $300 Mil. Drop In 2nd Half
Wyeth is seeing some stabilization in the Premarin franchise despite a 40% drop in prescriptions for Prempro and a 15% decline in Premarin scripts since release of the Women's Health Initiative study results
Flu Vaccine Schedule Expansion Could Cost Public Sector $60 Mil. Annually
Expanding influenza vaccination recommendations to include infants between six and 23 months and children who are household contacts of high-risk groups could increase costs to the public sector by $59.6 mil. annually